Determinants of Monocyte Apoptosis in Cardiorenal Syndrome Type 1
Background: Cardiorenal syndrome type 1 (CRS type 1) is characterized by a rapid worsening of cardiac function leading to acute kidney injury (AKI). Its pathophysiology is complex and not completely understood. In this study, we examined the role of apoptosis and the caspase pathways involved. Mater...
Saved in:
Published in: | Cardiorenal medicine Vol. 8; no. 3; pp. 208 - 216 |
---|---|
Main Authors: | , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
Basel, Switzerland
S. Karger AG
01-01-2018
|
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Abstract | Background: Cardiorenal syndrome type 1 (CRS type 1) is characterized by a rapid worsening of cardiac function leading to acute kidney injury (AKI). Its pathophysiology is complex and not completely understood. In this study, we examined the role of apoptosis and the caspase pathways involved. Material and Methods: We enrolled 40 acute heart failure (AHF) patients, 11 of whom developed AKI characterizing CRS type 1. We exposed the human cell line U937 to plasma from the CRS type 1 and AHF groups and then we evaluated apoptotic activity by annexin-V evaluation, determination of caspase-3, -8 and -9 levels, and BAX, BAD, and FAS gene expression. Results: We observed significant upregulation of apoptosis in monocytes exposed to CRS type 1 plasma compared to AHF, with increased levels of caspase-3 (p < 0.01), caspase-9 (p < 0.01), and caspase-8 (p < 0.03) showing activation of both intrinsic and extrinsic pathways. Furthermore, monocytes exposed to CRS type 1 plasma had increased gene expression of BAX and BAD (intrinsic pathways) (p = 0.010 for both). Furthermore, strong significant correlations between the caspase-9 levels and BAD and BAX gene expression were observed (Spearman ρ = – 0.76, p = 0.011, and ρ = – 0.72, p = 0.011). Conclusion: CRS type 1 induces dual apoptotic pathway activation in monocytes; the two pathways converged on caspase-3. Many factors may induce activation of both intrinsic and extrinsic apoptotic pathways in CRS type 1 patients, such as upregulation of proinflammatory cytokines and hypoxia/ischemia. Further investigations are necessary to corroborate the present findings, and to better understand the pathophysiological mechanism and consequent therapeutic and prognostic implications for CRS type 1. |
---|---|
AbstractList | Background: Cardiorenal syndrome type 1 (CRS type 1) is characterized by a rapid worsening of cardiac function leading to acute kidney injury (AKI). Its pathophysiology is complex and not completely understood. In this study, we examined the role of apoptosis and the caspase pathways involved. Material and Methods: We enrolled 40 acute heart failure (AHF) patients, 11 of whom developed AKI characterizing CRS type 1. We exposed the human cell line U937 to plasma from the CRS type 1 and AHF groups and then we evaluated apoptotic activity by annexin-V evaluation, determination of caspase-3, -8 and -9 levels, and BAX, BAD, and FAS gene expression. Results: We observed significant upregulation of apoptosis in monocytes exposed to CRS type 1 plasma compared to AHF, with increased levels of caspase-3 (p < 0.01), caspase-9 (p < 0.01), and caspase-8 (p < 0.03) showing activation of both intrinsic and extrinsic pathways. Furthermore, monocytes exposed to CRS type 1 plasma had increased gene expression of BAX and BAD (intrinsic pathways) (p = 0.010 for both). Furthermore, strong significant correlations between the caspase-9 levels and BAD and BAX gene expression were observed (Spearman ρ = – 0.76, p = 0.011, and ρ = – 0.72, p = 0.011). Conclusion: CRS type 1 induces dual apoptotic pathway activation in monocytes; the two pathways converged on caspase-3. Many factors may induce activation of both intrinsic and extrinsic apoptotic pathways in CRS type 1 patients, such as upregulation of proinflammatory cytokines and hypoxia/ischemia. Further investigations are necessary to corroborate the present findings, and to better understand the pathophysiological mechanism and consequent therapeutic and prognostic implications for CRS type 1. BACKGROUNDCardiorenal syndrome type 1 (CRS type 1) is characterized by a rapid worsening of cardiac function leading to acute kidney injury (AKI). Its pathophysiology is complex and not completely understood. In this study, we examined the role of apoptosis and the caspase pathways involved.MATERIAL AND METHODSWe enrolled 40 acute heart failure (AHF) patients, 11 of whom developed AKI characterizing CRS type 1. We exposed the human cell line U937 to plasma from the CRS type 1 and AHF groups and then we evaluated apoptotic activity by annexin-V evaluation, determination of caspase-3, -8 and -9 levels, and BAX, BAD, and FAS gene expression.RESULTSWe observed significant upregulation of apoptosis in monocytes exposed to CRS type 1 plasma compared to AHF, with increased levels of caspase-3 (p < 0.01), caspase-9 (p < 0.01), and caspase-8 (p < 0.03) showing activation of both intrinsic and extrinsic pathways. Furthermore, monocytes exposed to CRS type 1 plasma had increased gene expression of BAX and BAD (intrinsic pathways) (p = 0.010 for both). Furthermore, strong significant correlations between the caspase-9 levels and BAD and BAX gene expression were observed (Spearman ρ = - 0.76, p = 0.011, and ρ = - 0.72, p = 0.011).CONCLUSIONCRS type 1 induces dual apoptotic pathway activation in monocytes; the two pathways converged on caspase-3. Many factors may induce activation of both intrinsic and extrinsic apoptotic pathways in CRS type 1 patients, such as upregulation of proinflammatory cytokines and hypoxia/ischemia. Further investigations are necessary to corroborate the present findings, and to better understand the pathophysiological mechanism and consequent therapeutic and prognostic implications for CRS type 1. Cardiorenal syndrome type 1 (CRS type 1) is characterized by a rapid worsening of cardiac function leading to acute kidney injury (AKI). Its pathophysiology is complex and not completely understood. In this study, we examined the role of apoptosis and the caspase pathways involved. We enrolled 40 acute heart failure (AHF) patients, 11 of whom developed AKI characterizing CRS type 1. We exposed the human cell line U937 to plasma from the CRS type 1 and AHF groups and then we evaluated apoptotic activity by annexin-V evaluation, determination of caspase-3, -8 and -9 levels, and BAX, BAD, and FAS gene expression. We observed significant upregulation of apoptosis in monocytes exposed to CRS type 1 plasma compared to AHF, with increased levels of caspase-3 (p < 0.01), caspase-9 (p < 0.01), and caspase-8 (p < 0.03) showing activation of both intrinsic and extrinsic pathways. Furthermore, monocytes exposed to CRS type 1 plasma had increased gene expression of BAX and BAD (intrinsic pathways) (p = 0.010 for both). Furthermore, strong significant correlations between the caspase-9 levels and BAD and BAX gene expression were observed (Spearman ρ = - 0.76, p = 0.011, and ρ = - 0.72, p = 0.011). CRS type 1 induces dual apoptotic pathway activation in monocytes; the two pathways converged on caspase-3. Many factors may induce activation of both intrinsic and extrinsic apoptotic pathways in CRS type 1 patients, such as upregulation of proinflammatory cytokines and hypoxia/ischemia. Further investigations are necessary to corroborate the present findings, and to better understand the pathophysiological mechanism and consequent therapeutic and prognostic implications for CRS type 1. |
Author | Virzì, Grazia Maria de Cal, Massimo Breglia, Andrea Brocca, Alessandra Vescovo, Giorgio Ronco, Claudio Pastori, Silvia Bolin, Chiara |
AuthorAffiliation | a Department of Nephrology, Dialysis and Transplant, San Bortolo Hospital, Vicenza, Italy c Department of Internal Medicine, University of Trieste, Trieste, Italy f Internal Medicine Unit, Sant'Antonio Hospital, Padua, Italy e Internal Medicine, San Bortolo Hospital, Vicenza, Italy b IRRIV – International Renal Research Institute Vicenza, Vicenza, Italy d Department of Medicine DIMED, University of Padua Medical School, Padua, Italy |
AuthorAffiliation_xml | – name: b IRRIV – International Renal Research Institute Vicenza, Vicenza, Italy – name: a Department of Nephrology, Dialysis and Transplant, San Bortolo Hospital, Vicenza, Italy – name: f Internal Medicine Unit, Sant'Antonio Hospital, Padua, Italy – name: d Department of Medicine DIMED, University of Padua Medical School, Padua, Italy – name: e Internal Medicine, San Bortolo Hospital, Vicenza, Italy – name: c Department of Internal Medicine, University of Trieste, Trieste, Italy |
Author_xml | – sequence: 1 givenname: Andrea surname: Breglia fullname: Breglia, Andrea – sequence: 2 givenname: Grazia Maria surname: Virzì fullname: Virzì, Grazia Maria email: graziamaria.virzi@gmail.com – sequence: 3 givenname: Silvia surname: Pastori fullname: Pastori, Silvia – sequence: 4 givenname: Alessandra surname: Brocca fullname: Brocca, Alessandra – sequence: 5 givenname: Massimo surname: de Cal fullname: de Cal, Massimo – sequence: 6 givenname: Chiara surname: Bolin fullname: Bolin, Chiara – sequence: 7 givenname: Giorgio surname: Vescovo fullname: Vescovo, Giorgio – sequence: 8 givenname: Claudio surname: Ronco fullname: Ronco, Claudio |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/29847820$$D View this record in MEDLINE/PubMed |
BookMark | eNptkN1LwzAUxYNMnM49-C5S8EUfpkmapumLMOonbAi695A2yay2SU06of-9HZ1Fwad74fzuOZdzBEbGGgXACYJXCEXJNYSQMJaQZA8cIkrJLIogHu32kGE2BlPv3zsMRhQlMDoAY5wwEjMMD8H8VjXKVYURpvGB1cHSGpu3jQrmta0b6wsfFCZIhZOFdcqIMnhtjXS2UsGqrVWAjsG-FqVX092cgNX93Sp9nC2eH57S-WKWE0yaWUyl1CIXXayQimkcJVLrTIsY4RhJTHKJMIGUZBKHBEoSaYoE04JBkkUsnICb3rbeZJWSuTKNEyWvXVEJ13IrCv5XMcUbX9svTlEME0g7g4udgbOfG-UbXhU-V2UpjLIbzzEkcYJpTLdZlz2aO-u9U3qIQZBvS-dD6R179vuvgfypuANOe-BDuLVyAzDcn_8rpy_LnuC11OE3_yyT0g |
CitedBy_id | crossref_primary_10_1016_S0140_6736_19_32563_2 crossref_primary_10_3390_cells10071824 crossref_primary_10_1007_s40620_019_00613_2 crossref_primary_10_2174_1570161118666200628024027 crossref_primary_10_1007_s10529_018_2614_4 crossref_primary_10_1097_EC9_0000000000000049 crossref_primary_10_1159_000497748 |
Cites_doi | 10.1038/nrneph.2011.16 10.1073/pnas.0406421101 10.1159/000371898 10.1016/j.cellsig.2003.08.007 10.1159/000438459 10.1159/000444502 10.1016/S0002-9440(10)63747-9 10.1159/000349969 10.1159/000362650 10.1007/s40620-017-0425-7 10.1016/j.jacc.2008.07.051 10.1002/ijc.2910170504 10.1016/j.molcel.2010.09.022 10.1159/000122110 10.1038/onc.2009.44 10.2174/1568008054863754 10.1007/s10741-016-9534-y 10.1186/cc5713 10.1016/j.molcel.2010.01.025 10.1093/eurheartj/ehp507 10.1155/2015/391790 10.1038/ki.2009.224 10.1159/000452283 10.1016/S0955-0674(99)80034-9 10.1038/bjc.1972.33 10.1016/0092-8674(95)90071-3 10.1159/000443008 10.1681/ASN.2007121336 10.1159/000089452 10.1159/000438831 10.1038/ki.2011.120 |
ContentType | Journal Article |
Copyright | 2018 S. Karger AG, Basel 2018 S. Karger AG, Basel. Copyright © 2018 by S. Karger AG, Basel 2018 |
Copyright_xml | – notice: 2018 S. Karger AG, Basel – notice: 2018 S. Karger AG, Basel. – notice: Copyright © 2018 by S. Karger AG, Basel 2018 |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 5PM |
DOI | 10.1159/000488949 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
DatabaseTitleList | CrossRef MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: ECM name: MEDLINE url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
EISSN | 1664-5502 |
EndPage | 216 |
ExternalDocumentID | 10_1159_000488949 29847820 488949 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | 0~5 0~B 3O. 4.4 53G 8UI AAKDD AAYIC ABDBF ABJNI ABPAZ ACGFS ACPSR ADBBV AENEX AEYAO AFJJK AHMBA ALDHI ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS AZPMC BAWUL CYUIP DIK E0A EBS EJD EX3 FB. HYE HZ~ IY7 KUZGX M-- N9A O1H O9- OK1 OVD RKO RPM TEORI UJ6 WOW 3V. 7RV 7X7 8AO 8FI 8FJ ABUWG AFKRA BENPR BKEYQ BPHCQ BVXVI CAG CCPQU CGR COF CUY CVF ECM EIF FYUFA GROUPED_DOAJ HMCUK IAO IHR INH ITC NAPCQ NPM PQQKQ PROAC UKHRP AAYXX CITATION 7X8 5PM |
ID | FETCH-LOGICAL-c424t-76ddfaca782ade8f259dffbfa71271d24cd124064bd2340d45f61a8fa804b583 |
IEDL.DBID | RPM |
ISSN | 1664-3828 |
IngestDate | Tue Sep 17 21:03:16 EDT 2024 Sun Sep 29 07:46:13 EDT 2024 Thu Nov 21 20:24:36 EST 2024 Wed Oct 16 00:50:40 EDT 2024 Thu Aug 29 12:04:32 EDT 2024 Thu Sep 05 17:57:47 EDT 2024 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Keywords | Caspase Cardiorenal syndrome Monocytes Apoptosis |
Language | English |
License | Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. 2018 S. Karger AG, Basel. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c424t-76ddfaca782ade8f259dffbfa71271d24cd124064bd2340d45f61a8fa804b583 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Andrea Breglia and Grazia Maria Virzì contributed equally to this work. |
ORCID | 0000-0002-6697-4065 |
OpenAccessLink | https://www.karger.com/Article/Pdf/488949 |
PMID | 29847820 |
PQID | 2047926768 |
PQPubID | 23479 |
PageCount | 9 |
ParticipantIDs | karger_primary_488949 pubmedcentral_primary_oai_pubmedcentral_nih_gov_6170906 crossref_primary_10_1159_000488949 pubmed_primary_29847820 proquest_miscellaneous_2047926768 |
PublicationCentury | 2000 |
PublicationDate | 2018-01-01 |
PublicationDateYYYYMMDD | 2018-01-01 |
PublicationDate_xml | – month: 01 year: 2018 text: 2018-01-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Basel, Switzerland |
PublicationPlace_xml | – name: Basel, Switzerland – name: Switzerland – name: Allschwilerstrasse 10, P.O. Box · Postfach · Case postale, CH-4009, Basel, Switzerland · Schweiz · Suisse, Phone: +41 61 306 11 11, Fax: +41 61 306 12 34, karger@karger.ch |
PublicationTitle | Cardiorenal medicine |
PublicationTitleAlternate | Cardiorenal Med |
PublicationYear | 2018 |
Publisher | S. Karger AG |
Publisher_xml | – name: S. Karger AG |
References | Virzì GM, de Cal M, Day S, Brocca A, Cruz DN, Castellani C, et al: Pro-apoptotic effects of plasma from patients with cardiorenal syndrome on human tubular cells. Am J Nephrol 2015; 41: 474–484.2622878910.1159/000438459 Virzì GM, Clementi A, Brocca A, de Cal M, Ronco C: Molecular and genetic mechanisms involved in the pathogenesis of cardiorenal cross talk. Pathobiology 2016; 83: 201–210.2709674710.1159/000444502 Virzì GM, Torregrossa R, Cruz DN, Chionh CY, de Cal M, Soni SS, et al: Cardiorenal syndrome type 1 may be immunologically mediated: a pilot evaluation of monocyte apoptosis. Cardiorenal Med 2012; 2: 33–42.22493601 Bordoni V, Piroddi M, Galli F, de Cal M, Bonello M, Dimitri P, et al: Oxidant and carbonyl stress-related apoptosis in end-stage kidney disease: impact of membrane flux. Blood Purif 2006; 24: 149–156.1636185610.1159/000089452 Michiels C: Physiological and pathological responses to hypoxia. Am J Pathol 2004; 164: 1875–1882.1516162310.1016/S0002-9440(10)63747-9 de Cal M, Cruz DN, Corradi V, Nalesso F, Polanco N, Lentini P, et al: HLA-DR expression and apoptosis: a cross-sectional controlled study in hemodialysis and peritoneal dialysis patients. Blood Purif 2008; 26: 249–254.1837610610.1159/000122110 Wang Y, Fang Y, Teng J, Ding X: Acute kidney injury epidemiology: from recognition to intervention. Contrib Nephrol 2016; 187: 1–8.2688180210.1159/000443008 Pastori S, Virzì GM, Brocca A, de Cal M, Clementi A, Vescovo G, et al: Cardiorenal syndrome type 1: a defective regulation of monocyte apoptosis induced by proinflammatory and proapoptotic factors. Cardiorenal Med 2015; 5: 105–115.2599995910.1159/000371898 Faubel S, Edelstein CL: Caspases as drug targets in ischemic organ injury. Curr Drug Targets Immune Endocr Metabol Disord 2005; 5: 269–287.1617878810.2174/1568008054863754 Majmundar AJ, Wong WJ, Simon MC: Hypoxia-inducible factors and the response to hypoxic stress. Mol Cell 2010; 40: 294–309.2096542310.1016/j.molcel.2010.09.022 Haase M, Muller C, Damman K, Murray PT, Kellum JA, Ronco C, et al: Pathogenesis of cardiorenal syndrome type 1 in acute decompensated heart failure: workgroup statements from the eleventh consensus conference of the Acute Dialysis Quality Initiative (ADQI). Contrib Nephrol 2013; 182: 99–116.2368965810.1159/000349969 Ronco C, McCullough P, Anker SD, Anand I, Aspromonte N, Bagshaw SM, et al: Cardio-renal syndromes: report from the consensus conference of the acute dialysis quality initiative. Eur Heart J 2010; 31: 703–711.2003714610.1093/eurheartj/ehp507 Virzì GM, Clementi A, de Cal M, Brocca A, Day S, Pastori S, et al: Oxidative stress: dual pathway induction in cardiorenal syndrome type 1 pathogenesis. Oxid Med Cell Longev 2015; 2015: 391790.2582155410.1155/2015/391790 Thorburn A: Death receptor-induced cell killing. Cell Signal 2004; 16: 139–144.1463688410.1016/j.cellsig.2003.08.007 Sanz AB, Santamaria B, Ruiz-Ortega M, Egido J, Ortiz A: Mechanisms of renal apoptosis in health and disease. J Am Soc Nephrol 2008; 19: 1634–1642.1863284610.1681/ASN.2007121336 Hamar P, Song E, Kokeny G, Chen A, Ouyang N, Lieberman J: Small interfering RNA targeting Fas protects mice against renal ischemia-reperfusion injury. Proc Natl Acad Sci USA 2004; 101: 14883–14888.1546670910.1073/pnas.0406421101 Ronco C, Haapio M, House AA, Anavekar N, Bellomo R: Cardiorenal syndrome. J Am Coll Cardiol 2008; 52: 1527–1539.1900758810.1016/j.jacc.2008.07.051 Virzì GM, Clementi A, Ronco C: Cellular apoptosis in the cardiorenal axis. Heart Fail Rev 2016; 21: 177–189.2685214110.1007/s10741-016-9534-y Price PM, Safirstein RL, Megyesi J: The cell cycle and acute kidney injury. Kidney Int 2009; 76: 604–613.1953608010.1038/ki.2009.224 Havasi A, Borkan SC: Apoptosis and acute kidney injury. Kidney Int 2011; 80: 29–40.2156246910.1038/ki.2011.120 Sharfuddin AA, Molitoris BA: Pathophysiology of ischemic acute kidney injury. Nat Rev Nephrol 2011; 7: 189–200.2136451810.1038/nrneph.2011.16 Chipuk JE, Moldoveanu T, Llambi F, Parsons MJ, Green DR: The BCL-2 family reunion. Mol Cell 2010; 37: 299–310.2015955010.1016/j.molcel.2010.01.025 Virzì GM, Clementi A, Brocca A, de Cal M, Vescovo G, Granata A, et al: The hemodynamic and nonhemodynamic crosstalk in cardiorenal syndrome type 1. Cardiorenal Med 2014; 4: 103–112.2525403210.1159/000362650 Zhang J, Bottiglieri T, McCullough PA: The central role of endothelial dysfunction in cardiorenal syndrome. Cardiorenal Med 2017; 7: 104–117.2861178410.1159/000452283 Ashkenazi A, Dixit VM: Apoptosis control by death and decoy receptors. Curr Opin Cell Biol 1999; 11: 255–260.1020915310.1016/S0955-0674(99)80034-9 Danial NN: BAD: undertaker by night, candyman by day. Oncogene 2008; 27(suppl 1):S53–S70.1964150710.1038/onc.2009.44 Kerr JF, Wyllie AH, Currie AR: Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972; 26: 239–257.456102710.1038/bjc.1972.33 Chinnaiyan AM, O’Rourke K, Tewari M, Dixit VM: FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell 1995; 81: 505–512.753890710.1016/0092-8674(95)90071-3 Pastori S, Virzì GM, Brocca A, de Cal M, Cantaluppi V, Castellani C, et al: Cardiorenal syndrome type 1: activation of dual apoptotic pathways. Cardiorenal Med 2015; 5: 306–315.2664894710.1159/000438831 Virzì GM, Clementi A, Brocca A, de Cal M, Ronco C: Epigenetics: a potential key mechanism involved in the pathogenesis of cardiorenal syndromes. J Nephrol 2017, DOI: 10.1007/s40620-017-0425-7.2878071610.1007/s40620-017-0425-7 Sundstrom C, Nilsson K: Establishment and characterization of a human histiocytic lymphoma cell line (U-937). Int J Cancer 1976; 17: 565–577.17861110.1002/ijc.2910170504 Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG, et al: Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 2007; 11:R31.1733124510.1186/cc5713 ref13 ref12 ref15 ref14 ref31 ref30 ref11 ref10 ref2 ref1 ref17 ref16 ref19 ref18 ref24 ref23 ref26 ref25 ref20 ref22 ref21 ref28 ref27 ref29 ref8 ref7 ref9 ref4 ref3 ref6 ref5 |
References_xml | – ident: ref19 doi: 10.1038/nrneph.2011.16 – ident: ref31 doi: 10.1073/pnas.0406421101 – ident: ref7 doi: 10.1159/000371898 – ident: ref25 doi: 10.1016/j.cellsig.2003.08.007 – ident: ref5 doi: 10.1159/000438459 – ident: ref11 doi: 10.1159/000444502 – ident: ref22 doi: 10.1016/S0002-9440(10)63747-9 – ident: ref3 doi: 10.1159/000349969 – ident: ref8 doi: 10.1159/000362650 – ident: ref12 doi: 10.1007/s40620-017-0425-7 – ident: ref1 doi: 10.1016/j.jacc.2008.07.051 – ident: ref16 doi: 10.1002/ijc.2910170504 – ident: ref21 doi: 10.1016/j.molcel.2010.09.022 – ident: ref14 doi: 10.1159/000122110 – ident: ref26 doi: 10.1038/onc.2009.44 – ident: ref30 doi: 10.2174/1568008054863754 – ident: ref9 doi: 10.1007/s10741-016-9534-y – ident: ref15 doi: 10.1186/cc5713 – ident: ref27 doi: 10.1016/j.molcel.2010.01.025 – ident: ref2 doi: 10.1093/eurheartj/ehp507 – ident: ref6 doi: 10.1155/2015/391790 – ident: ref20 doi: 10.1038/ki.2009.224 – ident: ref10 doi: 10.1159/000452283 – ident: ref24 doi: 10.1016/S0955-0674(99)80034-9 – ident: ref18 doi: 10.1038/bjc.1972.33 – ident: ref23 doi: 10.1016/0092-8674(95)90071-3 – ident: ref4 doi: 10.1159/000443008 – ident: ref29 doi: 10.1681/ASN.2007121336 – ident: ref13 doi: 10.1159/000089452 – ident: ref28 doi: 10.1159/000438831 – ident: ref17 doi: 10.1038/ki.2011.120 |
SSID | ssj0000561905 |
Score | 2.1616454 |
Snippet | Background: Cardiorenal syndrome type 1 (CRS type 1) is characterized by a rapid worsening of cardiac function leading to acute kidney injury (AKI). Its... Cardiorenal syndrome type 1 (CRS type 1) is characterized by a rapid worsening of cardiac function leading to acute kidney injury (AKI). Its pathophysiology is... BACKGROUNDCardiorenal syndrome type 1 (CRS type 1) is characterized by a rapid worsening of cardiac function leading to acute kidney injury (AKI). Its... |
SourceID | pubmedcentral proquest crossref pubmed karger |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 208 |
SubjectTerms | Aged Aged, 80 and over Apoptosis bcl-2-Associated X Protein - genetics bcl-Associated Death Protein - genetics Cardio-Renal Syndrome - blood Cardio-Renal Syndrome - enzymology Cardio-Renal Syndrome - pathology Caspase 3 - blood Caspase 8 - blood Caspase 9 - blood Caspases - blood Enzyme Activation Fas Ligand Protein - genetics Female Gene Expression Heart Failure - blood Heart Failure - pathology Humans Male Middle Aged Monocytes - pathology Original Paper U937 Cells |
Title | Determinants of Monocyte Apoptosis in Cardiorenal Syndrome Type 1 |
URI | https://karger.com/doi/10.1159/000488949 https://www.ncbi.nlm.nih.gov/pubmed/29847820 https://search.proquest.com/docview/2047926768 https://pubmed.ncbi.nlm.nih.gov/PMC6170906 |
Volume | 8 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV07T8MwED7RioEFgSgQKMgg1rR5OIkzVi0VCwhRBrbI8dmiApKoj4F_j-0kVamYWP2Sc77k7nM-fwa4wzAMVWx5YZ5waeQzl0vmuTT0ZJrrmBuj2e94mCVPb2xyb2RyovYsjCXti3w-KD6_BsX83XIrqy8xbHliw-fHsRERT7142IGOzg23IHot6K0xgaUu-nFM3VBDikZRSEfuoT1EzVJq1EKDVH-ambnpeysk7X8YBvbir4Rzlze5FYimR3DYZJBkVM_0GPZkcQKjyRathZSK6He1FN8rSUZVWa3K5XxJ5gUZW_bpQpoBZo1WATFQlPg9eJ3ev44f3OZ2BFfQgK7cJEZUXHD9BBwlUxrHoFK54okfJD4GVKBvwjXNMQiphzRSsc-Z4syjecTCU-gWZSHPgWjEEWCKnop0L0YlQy_hAnVy4ieJwNyB29Y-WVVrYGQWO0RptrGnA73acpsmbXl_p3z88lhXZRUqB25aO2fasc3fCl7Icr3MAiN-H8R6cg6c1XbfDNGunAPJrxXZNDCi2b9rtC9Z8ezGdy7-3fMSDnTSxOptmD50V4u1vILOEtfX1hF_AEsp4PM |
link.rule.ids | 230,315,729,782,786,887,27933,27934,53800,53802 |
linkProvider | National Library of Medicine |
linkToHtml | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwEB7xqAQXoCqPwJa6Va9hncRJnONqWbRVWVSVPfQWOR5bXZVNon0c-PfYTrJaUE9c_VLsL5OZcT5_BviOURTpxPHCqPRZHHBfKE59FlGVFcbnJmj3O8aP6cMffjuyMjlxdxbGkfZlMbspn-Y35eyv41bWc9nveGL9X5OhFRHPaNLfhX1jr5RuJemNpLfJChx5MUgS5kcmqWg1hYzv7rtj1DxjVi80zMzHmdu7vrec0od_loO9-F_I-ZY5ueWK7o7fOYkTOGpjTzJoqj_Cjio_weB2ixBDKk2MlVfyeaXIoK7qVbWcLcmsJEPHW10oO8Bjq3JAbBJLglOY3o2mw7Hf3qvgSxaylZ8miFpIYWYuUHFtMiDUutAiDcI0wJBJDKyjZwWGEaPIYp0EgmvBKStiHp3BXlmV6gKIyVVCzJDq2PTiTHGkqZBowpogTSUWHnzr1jWvG_WM3GUdcZZvcPDgtFnxTZOuvPemfPh70lTlNWoPvnb45MYk7H8OUapqvcxDK5sfJubhPDhv8NoM0SHuQfoKyU0DK7f9usYA6GS3W8Au393zCxyMp5P7_P7Hw88rODShF282c3qwt1qs1WfYXeL62r3ML5XX9ng |
linkToPdf | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3LbtQwFL3qAyE2UESBQAEXsU3jOE7iLEczHbWCVlXbBbvI8UOMoEk0jwV_z7Xz0LTqim79UuIT597jnBwDfNNJktjM68KoCnkai1AaQUOeUFNUGHMz7fY7zm7yy59idupscsajvrxoX1WLk_rP3Um9-OW1le2digadWHR1MXUm4gXNolbbaBf2cc1StkXUO1tvZAZewBhnGQ8TJBa9rxDG78j_Si0K7jxDWYEvaOHO-94KTM9-Ox328rG086F6cisczV894UYO4GWfg5JJ1-Q17Jj6DUxmW8IY0liCq71Rf9eGTNqmXTerxYosajL1-tWlcQPc9G4HxJFZEh_C7fz0dnoW9ucrhIozvg7zTGsrlcS7l9oIi0xIW1tZmccsjzXjSscu4PNKs4RTzVObxVJYKSivUpG8hb26qc17IMhZmC40tSn2EtwITXOpNKY3cZ4rXQXwdZjbsu1cNErPPtKiHLEI4LCb9bHJUH70oHx6fdFVlThxARwPGJW4NNz3DlmbZrMqmbPPZxleXADvOszGIQbUA8jvoTk2cLbb92sQRG-_3YP24b97foHnV7N5-eP88vtHeIEZmOj2dI5gb73cmE-wu9Kbz_55_gdq4Pj4 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Determinants+of+Monocyte+Apoptosis+in+Cardiorenal+Syndrome+Type+1&rft.jtitle=Cardiorenal+medicine&rft.au=Breglia%2C+Andrea&rft.au=Virz%C3%AC%2C+Grazia+Maria&rft.au=Pastori%2C+Silvia&rft.au=Brocca%2C+Alessandra&rft.date=2018-01-01&rft.eissn=1664-5502&rft.volume=8&rft.issue=3&rft.spage=208&rft.epage=216&rft_id=info:doi/10.1159%2F000488949&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1664-3828&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1664-3828&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1664-3828&client=summon |